Title |
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial |
|---|---|
Involved |
Eolia Brissot (Verfasser)
Myriam Labopin (Verfasser) Helene Labussière (Verfasser) Gaelle Fossard (Verfasser)
Patrice Chevallier (Verfasser)
Thierry Guillaume (Verfasser) Ibrahim Yakoub-Agha (Verfasser) Micha Srour (Verfasser) Claude-Eric Bulabois (Verfasser) Anne Huynh (Verfasser) Sylvain Chantepie (Verfasser) Anne-Lise Menard (Verfasser) Marie-Therese Rubio (Verfasser) Patrice Ceballos (Verfasser) Rémy Dulery (Verfasser) Sabine Furst (Verfasser) Florent Malard (Verfasser) Didier Blaise (Verfasser) Mohamad Mohty (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Blood cancer journal 14, 1, 19.2.2024, date:12.2024, Seite 1-9 |
Published |
2024 |
Language |
|
Country |
|
Topic |
|
Subject |
Biomedical Research. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2404260720492.917109229353 (URN) |
Record ID |
1327600048 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: